BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16414331)

  • 41. Postmenopausal hormone therapy and the risk of breast cancer: the view of an epidemiologist.
    Li CI
    Maturitas; 2004 Sep; 49(1):44-50. PubMed ID: 15351095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 44. A critique of the Women's Health Initiative hormone therapy study.
    Klaiber EL; Vogel W; Rako S
    Fertil Steril; 2005 Dec; 84(6):1589-601. PubMed ID: 16359951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical versus natural menopause: cognitive issues.
    Henderson VW; Sherwin BB
    Menopause; 2007; 14(3 Pt 2):572-9. PubMed ID: 17476147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menopause: evidence-based practice.
    Blake J
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
    Hendrix SL; Wassertheil-Smoller S; Johnson KC; Howard BV; Kooperberg C; Rossouw JE; Trevisan M; Aragaki A; Baird AE; Bray PF; Buring JE; Criqui MH; Herrington D; Lynch JK; Rapp SR; Torner J;
    Circulation; 2006 May; 113(20):2425-34. PubMed ID: 16702472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage.
    Ettinger B
    Am J Med; 2005 Dec; 118 Suppl 12B():74-8. PubMed ID: 16414330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
    Gaspard U
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone therapy and coronary heart disease in young women.
    Weiner MG; Barnhart K; Xie D; Tannen RL
    Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormone use and patient concerns after the findings of the Women's Health Initiative.
    Rolnick SJ; Kopher RA; DeFor TA; Kelley ME
    Menopause; 2005; 12(4):399-404. PubMed ID: 16037754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postmenopausal hormone therapy in clinical perspective.
    Hodis HN; Mack WJ
    Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current status of hormone therapy and breast cancer.
    Norman RJ; MacLennan AH
    Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.